No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Boronic Acids
-
Bortezomib
-
Clinical Trials as Topic*
-
Hematologic Neoplasms / drug therapy
-
Hematologic Neoplasms / pathology
-
Humans
-
National Institutes of Health (U.S.)
-
Neoplasms / drug therapy*
-
Neoplasms / pathology
-
Patient Selection
-
Protease Inhibitors / therapeutic use*
-
Pyrazines
-
United States
Substances
-
Antineoplastic Agents
-
Boronic Acids
-
Protease Inhibitors
-
Pyrazines
-
Bortezomib